Federal Circuit Affirms Outcome, Holdings Of OxyContin Patent Trial
WASHINGTON, D.C. — A New York federal judge properly invalidated four patents covering the pain-relieving drug OxyContin following a three-week bench trial in 2013, the Federal Circuit U.S. Court of Appeals...To view the full article, register now.
Already a subscriber? Click here to view full article